[Foliculitis in a patient with Hodkins disease].
Garau
Margarita
M
Servicios de Microbiología. Hospital Universitario 12 de Octubre. Madrid. Spain.
Relaño
María Teresa
MT
Molina
Laura
L
del Palacio
Amalia
A
D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D002330:Carmustine / Q000008:administration & dosage / Q000009:adverse effects; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003606:Dacarbazine / Q000008:administration & dosage; D003881:Dermatomycoses / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D005499:Folliculitis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D008290:Malassezia / Q000302:isolation & purification*; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000009:adverse effects; D009894:Opportunistic Infections / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D014747:Vinblastine / Q000008:administration & dosage
D000935:Antifungal Agents; D003561:Cytarabine; D001761:Bleomycin; D017964:Itraconazole; D014747:Vinblastine; D005047:Etoposide; D003606:Dacarbazine; D003907:Dexamethasone; D004317:Doxorubicin; D008558:Melphalan; D002330:Carmustine